CHRS vs IVZ · rev $26.6M vs rev $3.57B
Coherus BioSciences Inc (CHRS) versus Invesco Plc (IVZ) — a side-by-side from cached financials, not a winner call.
Coherus BioSciences Inc (CHRS) is a biotechnology company listed on US.
Invesco Plc (IVZ) is a asset management company listed on NYSE.
Latest reported CHRS revenue for 2026-06-30 was $26.6M. Net income was -$59.0M. CHRS currently screens at market cap $223.7M.
Latest reported IVZ revenue for 2026-06-30 was $3.57B. Net income was $558.0M. IVZ currently screens at market cap $12.76B.
CHRS currently screens at market cap $223.7M. IVZ currently screens at market cap $12.76B.
Not investment advice. Open the CHRS and IVZ stock pages for the full models.
Not investment advice.